Considering that peripheral markers related to oxidative stress, inflammation, and neurotrophins are altered in patients with BD [26], studies with peripheral samples may yield promising findings in the assessment of neuroprogression pathways in BD. This evidence concerns the gene BDNF and Behcet disease.